Yousif Capital Management LLC Has $18.60 Million Position in Stryker Corporation $SYK

Yousif Capital Management LLC lowered its holdings in Stryker Corporation (NYSE:SYK) by 3.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,326 shares of the medical technology company’s stock after selling 1,655 shares during the quarter. Yousif Capital Management LLC’s holdings in Stryker were worth $18,604,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in SYK. Mid American Wealth Advisory Group Inc. bought a new stake in shares of Stryker in the 2nd quarter valued at approximately $26,000. Elevation Point Wealth Partners LLC bought a new position in shares of Stryker during the 2nd quarter worth approximately $28,000. Sachetta LLC boosted its stake in Stryker by 58.7% in the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock valued at $29,000 after buying an additional 27 shares in the last quarter. Kilter Group LLC bought a new stake in Stryker in the second quarter valued at $29,000. Finally, Howard Hughes Medical Institute acquired a new position in Stryker during the second quarter worth $29,000. Institutional investors own 77.09% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on SYK. Barclays upped their target price on shares of Stryker from $443.00 to $453.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Weiss Ratings restated a “hold (c+)” rating on shares of Stryker in a research report on Monday, December 15th. UBS Group set a $408.00 price objective on shares of Stryker in a report on Monday, October 13th. Rothschild Redb upgraded shares of Stryker to a “hold” rating in a research note on Thursday, September 18th. Finally, Sanford C. Bernstein restated an “outperform” rating on shares of Stryker in a research report on Monday, November 3rd. Thirteen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $431.84.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 276,173 shares of the business’s stock in a transaction dated Thursday, November 6th. The stock was sold at an average price of $353.28, for a total transaction of $97,566,397.44. Following the completion of the sale, the director directly owned 2,702,108 shares of the company’s stock, valued at approximately $954,600,714.24. The trade was a 9.27% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO William E. Berry, Jr. sold 1,953 shares of the company’s stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $365.49, for a total transaction of $713,801.97. Following the transaction, the chief accounting officer owned 2,833 shares in the company, valued at approximately $1,035,433.17. The trade was a 40.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 522,118 shares of company stock worth $185,381,932 over the last three months. 5.20% of the stock is currently owned by company insiders.

Stryker Price Performance

SYK opened at $356.50 on Tuesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.85 and a quick ratio of 1.13. The stock has a market capitalization of $136.33 billion, a P/E ratio of 46.85, a price-to-earnings-growth ratio of 2.51 and a beta of 0.89. The company’s 50 day simple moving average is $365.09 and its 200-day simple moving average is $377.26. Stryker Corporation has a one year low of $329.16 and a one year high of $406.19.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, October 30th. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.13 by $0.06. The firm had revenue of $6.06 billion for the quarter, compared to the consensus estimate of $6.04 billion. Stryker had a return on equity of 24.07% and a net margin of 12.07%.The business’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.87 EPS. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. Sell-side analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be issued a $0.88 dividend. This is a positive change from Stryker’s previous quarterly dividend of $0.84. This represents a $3.52 annualized dividend and a yield of 1.0%. The ex-dividend date is Wednesday, December 31st. Stryker’s dividend payout ratio (DPR) is 44.15%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.